Cargando…
A placebo-controlled study of sildenafil effects on cognition in schizophrenia
BACKGROUND: Phosphodiesterase 5 (PDE5) inhibitors increase cyclic guanosine monophosphate (cGMP) concentrations in the intracellular pathway activated by N-methyl-d-aspartic acid receptors which is believed to mediate long-term potentiation and memory consolidation. The PDE5 inhibitor sildenafil has...
Autores principales: | Goff, Donald C., Cather, Corinne, Freudenreich, Oliver, Henderson, David C., Evins, A. Eden, Culhane, Melissa A., Walsh, Jared P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704618/ https://www.ncbi.nlm.nih.gov/pubmed/18716761 http://dx.doi.org/10.1007/s00213-008-1278-5 |
Ejemplares similares
-
S94. INTEGRATED DIABETES MANAGEMENT FOR INDIVIDUALS WITH SERIOUS MENTAL ILLNESS
por: Cieslak, Kristina, et al.
Publicado: (2018) -
Hippocampal Subfield Volumes Predict Disengagement from Maintenance Treatment in First Episode Schizophrenia
por: Qi, Wei, et al.
Publicado: (2022) -
Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial
por: Pels, Anouk, et al.
Publicado: (2020) -
Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
por: Jashinski, Julia, et al.
Publicado: (2022) -
Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical Trial
por: Daumit, Gail L., et al.
Publicado: (2020)